|
1
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepatol. 16:589–604. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang A, Hallouch O, Chernyak V, Kamaya A
and Sirlin CB: Epidemiology of hepatocellular carcinoma: Target
population for surveillance and diagnosis. Abdom Radiol (NY).
43:13–25. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273 e1261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tabrizian P, Jibara G, Shrager B, Schwartz
M and Roayaie S: Recurrence of hepatocellular cancer after
resection: Patterns, treatments, and prognosis. Ann Surg.
261:947–955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shiina S, Sato K, Tateishi R, Shimizu M,
Ohama H, Hatanaka T, Takawa M, Nagamatsu H and Imai Y: Percutaneous
ablation for hepatocellular carcinoma: Comparison of various
ablation techniques and surgery. Can J Gastroenterol Hepatol.
2018:47561472018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirschhorn T and Stockwell BR: The
development of the concept of ferroptosis. Free Radic Biol Med.
133:130–143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Okada H and Mak TW: Pathways of apoptotic
and non-apoptotic death in tumour cells. Nat Rev Cancer. 4:592–603.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hassannia B, Vandenabeele P and Vanden
Berghe T: Targeting ferroptosis to iron out cancer. Cancer Cell.
35:830–849. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kagan VE, Mao G, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ho WE, Peh HY, Chan TK and Wong WS:
Artemisinins: Pharmacological actions beyond anti-malarial.
Pharmacol Ther. 142:126–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ooko E, Saeed ME, Kadioglu O, Sarvi S,
Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T:
Artemisinin derivatives induce iron-dependent cell death
(ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang N, Zeng GZ, Yin JL and Bian ZX:
Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects
ferroptosis in Burkitt's Lymphoma. Biochem Biophys Res Commun.
519:533–539. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eling N, Reuter L, Hazin J, Hamacher-Brady
A and Brady NR: Identification of artesunate as a specific
activator of ferroptosis in pancreatic cancer cells. Oncoscience.
2:517–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang D, Meng G, Zheng M, Zhang Y, Chen A,
Wu J and Wei J: The Glutaminase-1 inhibitor 968 enhances
dihydroartemisinin-mediated antitumor efficacy in hepatocellular
carcinoma cells. PLoS One. 11:e01664232016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang CZ, Zhang H, Yun J, Chen GG and Lai
PB: Dihydroartemisinin exhibits antitumor activity toward
hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol.
83:1278–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin R, Zhang Z, Chen L, Zhou Y, Zou P,
Feng C, Wang L and Liang G: Dihydroartemisinin (DHA) induces
ferroptosis and causes cell cycle arrest in head and neck carcinoma
cells. Cancer Lett. 381:165–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du J, Wang T, Li Y, Zhou Y, Wang X, Yu X,
Ren X, An Y, Wu Y, Sun W, et al: DHA inhibits proliferation and
induces ferroptosis of leukemia cells through autophagy dependent
degradation of ferritin. Free Radic Biol Med. 131:356–369. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Mi Y, Zhang X, Ma Q, Song Y, Zhang
L, Wang D, Xing J, Hou B, Li H, et al: Dihydroartemisinin-induced
unfolded protein response feedback attenuates ferroptosis via
PERK/ATF4/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res.
38:4022019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cubillos-Ruiz JR, Bettigole SE and
Glimcher LH: Tumorigenic and immunosuppressive effects of
endoplasmic reticulum stress in cancer. Cell. 168:692–706. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang M and Kaufman RJ: The impact of the
endoplasmic reticulum protein-folding environment on cancer
development. Nat Rev Cancer. 14:581–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen D, Fan Z, Rauh M, Buchfelder M,
Eyupoglu IY and Savaskan N: ATF4 promotes angiogenesis and neuronal
cell death and confers ferroptosis in a xCT-dependent manner.
Oncogene. 36:5593–5608. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang C, Dai CY, Mei Z, Jiang MJ, Gu DN,
Huang Q and Tian L: microRNA-193a stimulates pancreatic cancer cell
repopulation and metastasis through modulating
TGF-beta2/TGF-betaRIII signalings. J Exp Clin Cancer Res.
37:252018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tadvalkar G, Pal-Ghosh S, Pajoohesh-Ganji
A and Stepp MA: The impact of euthanasia and enucleation on mouse
corneal epithelial axon density and nerve terminal morphology. Ocul
Surf. 18:821–828. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo M, Wu L, Zhang K, Wang H, Zhang T,
Gutierrez L, O'Connell D, Zhang P, Li Y, Gao T, et al: miR-137
regulates ferroptosis by targeting glutamine transporter SLC1A5 in
melanoma. Cell Death Differ. 25:1457–1472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Amaral JD, Castro RE, Steer CJ and
Rodrigues CM: p53 and the regulation of hepatocyte apoptosis:
Implications for disease pathogenesis. Trends Mol Med. 15:531–541.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Banjac A, Perisic T, Sato H, Seiler A,
Bannai S, Weiss N, Kölle P, Tschoep K, Issels RD, Daniel PT, et al:
The cystine/cysteine cycle: A redox cycle regulating susceptibility
versus resistance to cell death. Oncogene. 27:1618–1628. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hou J, Wang D, Zhang R and Wang H:
Experimental therapy of hepatoma with artemisinin and its
derivatives: In vitro and in vivo activity, chemosensitization, and
mechanisms of action. Clin Cancer Res. 14:5519–5530. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ursini F, Maiorino M, Valente M, Ferri L
and Gregolin C: Purification from pig liver of a protein which
protects liposomes and biomembranes from peroxidative degradation
and exhibits glutathione peroxidase activity on phosphatidylcholine
hydroperoxides. Biochim Biophys Acta. 710:197–211. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Walter F, Schmid J, Dussmann H, Concannon
CG and Prehn JH: Imaging of single cell responses to ER stress
indicates that the relative dynamics of IRE1/XBP1 and PERK/ATF4
signalling rather than a switch between signalling branches
determine cell survival. Cell Death Differ. 22:1502–1516. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bai T, Liang R, Zhu R, Wang W, Zhou L and
Sun Y: MicroRNA-214-3p enhances erastin-induced ferroptosis by
targeting ATF4 in hepatoma cells. J Cell Physiol. 235:5637–5648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kumar A, Tikoo S, Maity S, Sengupta S,
Sengupta S, Kaur A and Bachhawat AK: Mammalian proapoptotic factor
ChaC1 and its homologues function as gamma-glutamyl
cyclotransferases acting specifically on glutathione. EMBO Rep.
13:1095–1101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma MKF, Lau EYT, Leung DHW, Lo J, Ho NPY,
Cheng LKW, Ma S, Lin CH, Copland JA, Ding J, et al: Stearoyl-CoA
desaturase regulates sorafenib resistance via modulation of ER
stress-induced differentiation. J Hepatol. 67:979–990. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakagawa H, Umemura A, Taniguchi K,
Font-Burgada J, Dhar D, Ogata H, Zhong Z, Valasek MA, Seki E,
Hidalgo J, et al: ER stress cooperates with hypernutrition to
trigger TNF-dependent spontaneous HCC development. Cancer Cell.
26:331–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
